Exiqon A/S and Asuragen, Inc. Sign Agreement for Real-Time PCR Services  
6/10/2013 9:38:14 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Exiqon A/S (NASDAQ OMX: “EXQ”), a leading supplier of high-value products for gene expression analysis, and Asuragen, Inc. a fully integrated molecular diagnostics company focused on oncology and companion diagnostics with special capabilities in the area of miRNA, today announced the signing of a Service Center Agreement, allowing Asuragen to provide real-time PCR services based on Exiqon’s miRCURY LNA™ Universal RT microRNA PCR products.

Help employers find you! Check out all the jobs and post your resume.